917392-54-2 (4-甲基-3-(4-(吡啶-3-基)嘧啶-2-基氨基)苯甲酸甲酯,Methyl 4-Methyl-3-4-(pyridin-3-yl)pyrimidin-2-ylaminobenzoate)

CAS号:
917392-54-2
中文名称:
4-甲基-3-(4-(吡啶-3-基)嘧啶-2-基氨基)苯甲酸甲酯
英文名称:
Methyl 4-Methyl-3-4-(pyridin-3-yl)pyrimidin-2-ylaminobenzoate
分子式:
C18H16N4O2
分子量:
320.345243453979

4-甲基-3-(4-(吡啶-3-基)嘧啶-2-基氨基)苯甲酸甲酯(917392-54-2)名称与标识符

名称

中文别名:
4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯甲酸甲酯;4-甲基-3-(4-(吡啶-3-基)嘧啶-2-基氨基)苯甲酸甲酯;
英文别名:
Methyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate;4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid methyl ester;Benzoicacid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, methyl ester;METHYL 4-METHYL-3-(4-(PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)BENZOATE;methyl 4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzoate;Everolimus;Methyl 4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoate;917392-54-2;DB-079163;Methyl4-Methyl-3-((4-(pyridin-3-yl)pyriMidin-2-yl)aMino)benzoate;UNII-HKX2YWY42Y;CS-0321831;NS00008500;Methyl 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic Acid Ester; Benzoic acid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, methyl ester; Methyl 4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoate; Methyl 4-Methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoate; Nilotinib methyl ester;AKOS015917907;NILOTINIB HYDROCHLORIDE MONOHYDRATE IMPURITY G [EP IMPURITY];METHYL 4-METHYL-3-{[4-(PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}BENZOATE;BECBKQYLJDEVDN-UHFFFAOYSA-N;4-Methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzoic acid methyl ester;HKX2YWY42Y;SCHEMBL534524;DTXSID40589940;EC 700-542-4;MFCD16619370;

标识符

MDL:
MFCD16619370
InChIKey:
BECBKQYLJDEVDN-UHFFFAOYSA-N
Inchi:
1S/C18H16N4O2/c1-12-5-6-13(17(23)24-2)10-16(12)22-18-20-9-7-15(21-18)14-4-3-8-19-11-14/h3-11H,1-2H3,(H,20,21,22)
SMILES:
O=C(C1C=C(NC2N=C(C3C=CC=NC=3)C=CN=2)C(C)=CC=1)OC

4-甲基-3-(4-(吡啶-3-基)嘧啶-2-基氨基)苯甲酸甲酯(917392-54-2)物化性质

实验特性

  • 折射率 : 1.634
  • 沸点 : 538.59°C at 760 mmHg
  • 闪点 : 279.53°C
  • 密度 : 1.258

计算特性

  • 精确分子量 : 320.127
  • 氢键供体数量 : 1
  • 氢键受体数量 : 6
  • 可旋转化学键数量 : 5
  • 同位素质量 : 320.127
  • 重原子数量 : 24
  • 复杂度 : 420
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 2.9
  • 拓扑分子极性表面积 : 77A^2

4-甲基-3-(4-(吡啶-3-基)嘧啶-2-基氨基)苯甲酸甲酯(917392-54-2)安全信息

4-甲基-3-(4-(吡啶-3-基)嘧啶-2-基氨基)苯甲酸甲酯(917392-54-2)推荐厂家 更多厂家(31)

4-甲基-3-(4-(吡啶-3-基)嘧啶-2-基氨基)苯甲酸甲酯(917392-54-2)合成路线

合成路线:1 步
反应条件:
参考文献:
Completely N1-selective palladium-catalyzed arylation of unsymmetric imidazoles: application to the synthesis of nilotinib
Ueda, Satoshi; et al, Journal of the American Chemical Society, 2012, 134(1), 700-706
合成路线:1 步
反应条件:
参考文献:
Syntheses and biological evaluation of 1,2,3-triazole and 1,3,4-oxadiazole derivatives of imatinib
Li, Yong-Tao; et al, Bioorganic & Medicinal Chemistry Letters, 2016, 26(5), 1419-1427
合成路线:1 步
反应条件:
参考文献:
Rapid synthesis of Abelson tyrosine kinase inhibitors using click chemistry
Kalesh, Karunakaran A.; et al, Organic & Biomolecular Chemistry, 2009, 7(24), 5129-5136
合成路线:1 步
反应条件:
参考文献:
Protective effect of a new heterocyclic compound on acute tracheobronchitis via reducing IL-6 and TNF-α content and PKA-NF-κB pathway activation
Han, Ai-Ping; et al, Main Group Chemistry, 2021, 20(1), 41-48
合成路线:1 步
参考文献:
Pharmacophore Modeling of Nilotinib as an Inhibitor of ATP-Binding Cassette Drug Transporters and BCR-ABL Kinase Using a Three-Dimensional Quantitative Structure-Activity Relationship Approach
Shukla, Suneet; et al, Molecular Pharmaceutics, 2014, 11(7), 2313-2322
合成路线:2 步
反应条件:
参考文献:
Protective effect of a new heterocyclic compound on acute tracheobronchitis via reducing IL-6 and TNF-α content and PKA-NF-κB pathway activation
Han, Ai-Ping; et al, Main Group Chemistry, 2021, 20(1), 41-48
合成路线:2 步
反应条件:
参考文献:
Completely N1-selective palladium-catalyzed arylation of unsymmetric imidazoles: application to the synthesis of nilotinib
Ueda, Satoshi; et al, Journal of the American Chemical Society, 2012, 134(1), 700-706
合成路线:2 步
反应条件:
参考文献:
Rapid synthesis of Abelson tyrosine kinase inhibitors using click chemistry
Kalesh, Karunakaran A.; et al, Organic & Biomolecular Chemistry, 2009, 7(24), 5129-5136
合成路线:2 步
反应条件:
参考文献:
Rapid synthesis of Abelson tyrosine kinase inhibitors using click chemistry
Kalesh, Karunakaran A.; et al, Organic & Biomolecular Chemistry, 2009, 7(24), 5129-5136